Extreme high dividend stock BB Biotech

Huge dividend BB Biotech

Investors in BB Biotech can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Per share the analysts expect a dividend of 3,37 CHF per share. The dividend yield is then 4,85 percent. The average dividend yield of the biotech companies is a low 0,5 percent.

Dividend returns BB Biotech

Tomorrow BB Biotech will publish it's past quarter's results. Over the current book year the total revenue will be 0 million CHF (consensus estimates). This is hugely lower than 2017's revenue of 730,05 million CHF.

Historical revenues and results BB Biotech plus estimates 2018

The analysts expect for 2018 a net profit of 649 million CHF. For this year the consensus of the result per share is a profit of 11,82 CHF. The price/earnings-ratio is then 5,88.

Based on the current number of outstanding shares BB Biotech 's market capitalization is 3,85 billion CHF. The BB Biotech stock was the past 12 months quite volatile. Since last October the stock is 7 percent higher. This year the stock price moved between 62 and 75 CHF. Since 2008 the stock price is almost 360 percent higher.

Historical stock prices BB Biotech

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.